Turkish Validity and Reliability of SGRQ-I
Launched by SAGLIK BILIMLERI UNIVERSITESI · Dec 6, 2021
Trial Information
Current as of August 02, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on creating a Turkish version of the Saint George Respiratory Questionnaire (SGRQ), which helps assess the quality of life for patients with Idiopathic Pulmonary Fibrosis (IPF), a serious lung condition. Currently, there isn't a commonly used questionnaire in Turkish for IPF patients, so this study aims to translate and validate this important tool. By participating, you can help ensure that Turkish-speaking patients with IPF have access to a questionnaire that reflects their experiences and can improve their care.
To be eligible for this trial, you need to be over 18 years old and have a diagnosis of Idiopathic Pulmonary Fibrosis. It's also important that you can read and understand Turkish. However, if you have experienced a worsening of your symptoms in the last six weeks, have other health issues that make it hard for you to move around, or have difficulties with thinking and understanding, you won't be able to participate. If you join the study, you can expect to help contribute to a valuable resource that could benefit many others in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Be over 18 years old
- • Having a Diagnosis of Idiopathic Pulmonary Fibrosis
- • To be literate in Turkish
- Exclusion Criteria:
- • Exacerbation or exacerbation in the last 6 weeks
- • Presence of comorbidities affecting ambulation
- • Cognitive impairment
About Saglik Bilimleri Universitesi
Saglik Bilimleri Universitesi, or the University of Health Sciences, is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, the university focuses on translating scientific discoveries into practical applications that enhance patient care and public health outcomes. Its commitment to rigorous ethical standards and comprehensive training equips researchers and healthcare professionals to contribute effectively to the global medical community. Through its clinical trial initiatives, Saglik Bilimleri Universitesi aims to address pressing health challenges and foster the development of new therapeutic strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
İstanbul, üsküdar, Turkey
İstanbul, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials